Professional Experience
Dr. Callesen has extensive experience in clinical practice and oncology research:
- Current Position: Medical Doctor and Postdoctoral Researcher at Aarhus University Hospital, Department of Oncology
- Research Focus: ctDNA-guided treatment strategies, primarily in colorectal cancer
- Leadership Roles: Principal Investigator in national projects including OPTIMISE and CURE studies
- Clinical Contributions: Development of diagnostic and therapeutic protocols to enhance patient care in oncology
Academic Contributions
Dr. Callesen has significantly contributed to research, education, and mentorship in oncology:
- Research Interests: Clinical applications of ctDNA to monitor treatment response and detect minimal residual disease
- Publications: Author of multiple peer-reviewed articles advancing cancer diagnostics and therapy
- Collaborations: Engaged in national and international research collaborations
- Teaching and Mentorship: Mentors junior researchers and participates in educational programs for medical professionals
Areas of Expertise
Dr. Callesen specializes in several key areas of oncology, offering advanced patient care:
- Colorectal Cancer: Uses ctDNA for treatment monitoring and detecting recurrence
- Circulating Tumor DNA (ctDNA): Employs non-invasive diagnostic methods to guide personalized therapy
- Liquid Biopsy Techniques: Implements advanced assays for early detection and treatment optimization
- Translational Oncology Research: Bridges laboratory findings to clinical applications for improved patient outcomes
Publications and Research
Dr. Callesen has contributed to several impactful publications in oncology:
- Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group: Scientific Reports, 2023
- The Importance of Feasibility Assessment in the Design of ctDNA Guided Trials – Results From the OPTIPAL II Study: Clinical Colorectal Cancer, 2023
- Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy: Clinical and Translational Radiation Oncology, 2022
- Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis: Therapeutic Advances in Medical Oncology, 2022
Patient Care Philosophy
Dr. Callesen emphasizes a compassionate, patient-centered approach to care:
- Communication and Empathy: Promotes clear communication and shared decision-making in treatment planning
- Innovative Care: Integrates advanced diagnostics such as ctDNA into patient care strategies
- International Patients: Supports consultations and treatment planning for patients worldwide
- Cultural Sensitivity: Provides care that respects and responds to diverse cultural needs
Professional Affiliations
Dr. Callesen maintains memberships in leading oncology organizations to stay current with developments in her field:
- Danish Society for Clinical Oncology (DSKO): Member
- European Society for Medical Oncology (ESMO): Member
- American Association for Cancer Research (AACR): Member
- Board Certifications: Licensed Medical Doctor in Denmark
FAQs
- Is Dr. Louise Bach Callesen board-certified?
- Yes, she is a licensed Medical Doctor in Denmark with specialization in oncology.
- What types of surgeries does Dr. Callesen perform?
- Dr. Callesen focuses on non-invasive diagnostics and research and does not perform surgeries.
- Does Dr. Callesen treat international patients?
- Yes, she provides consultations and treatment planning for international patients.
- How long is the typical hospital stay for patients under Dr. Callesen’s care?
- Hospital stay depends on the individual treatment plan and patient condition.
- What languages does Dr. Callesen speak?
- She is fluent in Danish and English, allowing effective communication with diverse patients.
